Skip to content

Frontlight ResearchEarly access

Trial site

CancerCare Manitoba (Site 0119)

Winnipeg, Manitoba R3E 0V9, CanadaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Kidney cancer

Closed trials

Completed
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
NCT03142334· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

CancerCare Manitoba (Site 0119): trial site – Frontlight Research